| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 8 | |
| #2 | Australia | 6 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Sugars | |
| #4 | Specific use of cosmetics | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Brown David A | 13 |
| #2 | Ren Wu Yun | 10 |
| #3 | Khorlin Alexander A | 9 |
| #4 | Lesiak Krystyna | 7 |
| #5 | Watanabe Kyoichi A | 4 |
| #6 | Ren Wu Yunn | 2 |
| #7 | Seidman Michael | 2 |
| #8 | Pankiewicz Krzysztof W | 1 |
| #9 | Kyoichi Watanabe | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO02051395A1 | Treatment of neurodegenerative diseases | |
| AU6565998A | Pharmaceutical compositions and methods | |
| WO9855085A1 | Pharmaceutical compositions and methods | |
| AU1710997A | Oligonucleotide analogs |